Topical Diclofenac and Topical DFMO Chemoprevention Trial in Subjects With a History of Skin Cancer

NCT04091022 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

64

Enrollment

OTHER

Sponsor class

Conditions

Non-melanoma Skin Cancer

Interventions

DRUG: Solaraze and Vaniqa

Sponsor

University of Alabama at Birmingham

Collaborators

[object Object]
[object Object]